Researchers at Indiana University School of Medicine reported Tuesday in the Nature Publishing Group's leading journal in psychiatry, Molecular Psychiatry, that they have developed blood tests and questionnaire instruments that can predict with more than 90 percent accuracy which of those patients will begin thinking of suicide, or attempt it.
"We believe that widespread adoption of risk prediction tests based on these findings during healthcare assessments will enable clinicians to intervene with lifestyle changes or treatments that can save lives," said Alexander B. Niculescu III, M.D., Ph.D., professor of psychiatry and medical neuroscience at the IU School of Medicine and attending psychiatrist and research and development investigator at the Richard L. Roudebush Veterans Affairs Medical Center.
Through the use of functional magnetic resonance imaging, investigators analyzed the brains of 30 heroin-addicted individuals after a long period of abstinence (more than 3 years) and compared the results with those of 30 healthy controls.
The team found that in the former heroin users, there was significant dysfunctional activity in the nucleus accumbens region of the brain, an area that is involved in appetitive drive and reward-seeking behavior.
The Journal of Neuroscience Research findings suggests that intense craving for drugs may be triggered in the presence of stressors or other environmental cues in individuals who have successfully remained abstinent for long periods of time. Taking this into consideration may aid the development of treatment and rehabilitation strategies for those suffering from drug addiction.
Presumably by preventing inflammation......
Since current treatments for schizophrenia can only relieve symptoms, and omega-3 PUFAs are considered safe and generally beneficial for health, scientists decided to investigate their potential as a possible preventative measure. Although tests cannot assert who will and will not develop schizophrenia, over the years scientists have identified a clinical syndrome characterized by various signs and symptoms that is associated with an extremely high risk of developing a psychotic disorder. These “ultra-high risk” criteria tend to gradually manifest throughout adolescence and have helped clinicians identify young people who are likely to transition to psychosis.
Given that early intervention is generally associated with better outcomes, scientists from the University of Melbourne decided to investigate whether omega-3 PUFA supplementation in these high-risk individuals could prevent progression to psychotic disorder. The first phase of their research began almost 10 years ago when they enrolled 81 participants between the ages of 13 and 25 into a clinical trial. Half the individuals received omega-3 PUFAs for 12 weeks, and the others received placebos. They found that the intervention successfully prevented a first episode of psychotic disorder for up to one year.
Amazing Pinterest Board from Sarah Olson.......
All things brain: right/left brain; amygdala and fear response; brain-based learning; changes caused by trauma.
Those at most risk are so-called 'revolvers' or 'churners' - frequently in and out of prison. Their lives revolve between chaotic existences in the community and spells in custody. As such, often they are not under the supervision of probation services, neither do they have meaningful contact with primary care or specialist mental health services.
The research team interviewed 35 male offenders from a Category B medium secure prison in the South West of England. Interviews took place one week prior to and approximately six weeks after release. The interviewees were aged between 18 and 52.
Eighteen of the 35 interviewees had attempted suicide at some time. Most had troubled personal lives: 24 had experienced family breakdown or abandonment as children; 26 had tales of physical abuse or neglect; and 15 experienced excessive drug and alcohol use in their family homes. All reported recent personal problems.
Led by Prof Morten Kringelbach, the Oxford team's systematic meta-analysis of all brain research on PTSD is published in the journal Neuroscience and Biobehavioural Reviews. The research is part of a larger programme on PTSD in British war veterans run by the Scars of War Foundation based at The Queen's College, University of Oxford. The foundation uses neuroscience to advance understanding of the effects of war and disaster.
The research team's initial survey of the scientific literature for all the published studies reporting brain activity in individuals with a diagnosis of PTSD yielded over 2000 records. This number was then reduced using stringent criteria to ensure the highest possible data quality for processing with meta-analytic tools.
The team separated studies by type of control group: trauma-exposed (those who had experienced trauma but did not have a diagnosis of PTSD) and trauma-naïve (those who had not experienced trauma), and compared the individuals with PTSD to both groups. This yielded an insight into how the abnormalities in functional brain activity in PTSD comprise a whole-brain network.
The analysis showed that there were differences between the brain activity of individuals with PTSD and that of the groups of both trauma-exposed and trauma-naïve participants.
This suggests that even in the absence of symptoms, trauma may have an enduring effect on brain function. Critically, the research found that in parts of a region of the brain called the basal ganglia, brain activity was different when comparing people with PTSD to the trauma-exposed group.